Table 2.
Demographic and clinical characteristics among infarct pattern groups
| DWI lesion patterns | P | |||
|---|---|---|---|---|
| Territory n = 46 (19.9%) |
Lobar/Deep n = 118 (51.1%) |
Small scattered n = 67 (29.0%) |
(Territory vs. others) | |
| NIHSS score on admission | 16.3 ± 6.3 | 9.6 ± 6.1 | 4.1 ± 4.2 | < 0.001 |
| Vascular risk factors | ||||
| Age | 68.3 ± .12.4 | 71.6 ± 11.4 | 69.3 ± 9.3 | 0.324 |
| Male gender | 29(63.0%) | 57(48.3%) | 32(47.8%) | 0.070 |
| Hypertension | 28(60.9%) | 84(71.2%) | 48(71.6%) | 0.733 |
| Diabetes | 10(21.7%) | 20(16.9%) | 14(20.9%) | 0.603 |
| Previous TIA/stroke | 13(28.3%) | 25(21.2%) | 21(31.3%) | 0.636 |
| CHADS2*score | 0.684 | |||
| 0-1 | 21(45.7%) | 51(43.2%) | 30(44.8%) | |
| 2-3 | 18(39.1%) | 55(46.6%) | 28(41.8%) | |
| 4-5 | 7(15.2%) | 12(10.2%) | 9(13.4%) | |
| Dysrhythmia | ||||
| Paroxysmal atrial fibrillation | 15(32.6%) | 44(37.3%) | 23(34.3%) | 0.647 |
| Concomitant valvular heart disease | 5(11.1%) | 14(12.0%) | 5(7.5%) | 0.878 |
| Heart rate (/min) | 84.2 ± 25.1 | 84.2 ± 21.0 | 79.8 ± 19.9 | 0.501 |
| Medications prior to onset | ||||
| Antiplatelet agents user | 15(32.6%) | 45(39.1%) | 31(47.0%) | 0.246 |
| Warfarin user | 8(17.4%) | 12(10.2%) | 8(11.9.%) | 0.221 |
| Laboratory findings | ||||
| D-dimer, mg/dL | 2.37 ± 3.76 | 1.89 ± 3.19 | 1.29 ± 2.03 | 0.105 |
| Fibrinogen, mg/dL | 340.72 ± 100.6 | 324.5 ± 88.0 | 319.4 ± 77.7 | 0.230 |
| C-reactive protein, mg/dL | 0.84 ± 1.14 | 0.93 ± 2.22 | 0.87 ± 2.41 | 0.041 |
| Prothrombin Time, INR | 1.08 ± 0.11 | 1.07 ± 0.12 | 1.08 ± 0.10 | 0.667 |
| Transthoracic echocardiogram finding | ||||
| Left ventricular ejection fraction, % | 55.6 ± 16.3 | 60.0 ± 10.2 | 61.1 ± 11.1 | 0.008 |
| Left atrium size, ml | 47.2 ± 7.5 | 47.8 ± 9.2 | 46.4 ± 8.1 | 0.991 |
| E/e' ratio | 14.53 ± 10.21 | 15.11 ± 9.00 | 13.71. ± 6.16 | 0.478 |
| DT, ms | 237.4 ± 131.9 | 215.9 ± 118.9 | 244.8 ± 163.3 | 0.317 |
*In CHADS2, S indicates prior stroke or transient ischemic attack